BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6221110)

  • 1. Impaired generation of helper T cells in a patient with chronic mucocutaneous candidiasis and malignant thymoma.
    Ruiz-Argüelles A; Jett JR; Ritts RE
    J Clin Lab Immunol; 1983 Mar; 10(3):165-9. PubMed ID: 6221110
    [No Abstract]   [Full Text] [Related]  

  • 2. Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function.
    Gatenby P; Basten A; Adams E
    J Clin Lab Immunol; 1980 May; 3(3):209-16. PubMed ID: 7420408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune defect following thymoma. Case description and review].
    Manzanell C; Morell A; Keller H
    Schweiz Med Wochenschr; 1985 Oct; 115(40):1393-401. PubMed ID: 2933805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic mucocutaneous candidiasis and keratitis associated with malignant thymoma.
    Liesegang TJ; Palestine RF; Su WP
    Ann Ophthalmol; 1983 Feb; 15(2):174-81. PubMed ID: 6838096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient neutrophil function in a patient with chronic mucocutaneous candidiasis, thymoma and myasthenia gravis.
    Mobacken H; Lindholm L; Olling S
    Acta Derm Venereol; 1977; 57(4):335-9. PubMed ID: 70927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient abrogation of immunosuppression in a patient with chronic mucocutaneous candidiasis following vaccination with Candida albicans.
    Burford-Mason AP; Matthews RC; Williams JR
    J Infect; 1987 Mar; 14(2):147-57. PubMed ID: 2952735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant thymoma with lymphocytopenia and IgM immunoglobulin].
    Lederer B; Gabl F
    Verh Dtsch Ges Pathol; 1970; 54():319-22. PubMed ID: 4104556
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and immunologic studies of the use of thymus polypeptide factor (thymostimulin) in chronic mucocutaneous candidiasis].
    Lutz G; Niedecken HW; Bauer R; Kreysel HW
    Hautarzt; 1986 Mar; 37(3):142-5. PubMed ID: 3486176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant thymoma associated with T-cell lymphocytosis. A case report with immunophenotypic and gene rearrangement analysis.
    Medeiros LJ; Bhagat SK; Naylor P; Fowler D; Jaffe ES; Stetler-Stevenson M
    Arch Pathol Lab Med; 1993 Mar; 117(3):279-83. PubMed ID: 8382915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset chronic mucocutaneous and ocular candidiasis and malignant thymoma.
    Palestine RF; Su WP; Liesegang TJ
    Arch Dermatol; 1983 Jul; 119(7):580-6. PubMed ID: 6305286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recurrent lung infection and late-onset immunitary deficiency related to a thymoma (author's transl)].
    Wipf R; Stinghe R; Girard JP; Kapanci Y
    Schweiz Rundsch Med Prax; 1982 Apr; 71(16):681-4. PubMed ID: 7111186
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymoma and hypogammaglobulinaemia with and without T suppressor cells.
    Brenner MK; Reittie JG; Chadda HR; Pollock A; Asherson GL
    Clin Exp Immunol; 1984 Dec; 58(3):619-24. PubMed ID: 6239720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic mucocutaneous candidiasis with widespread dermatophyte infection: the trailing scale sign.
    Rosen RM
    Cutis; 1996 Feb; 57(2):82-4. PubMed ID: 8646859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic mucocutaneous candidiasis. Cutaneous expression of immunologic anomalies. Report of a case].
    Pérez Suárez de Durandeau L; Salinas Carmona MC; Silva Siwady JG; Hinojosa Ayala JR
    Med Cutan Ibero Lat Am; 1986; 14(5):357-63. PubMed ID: 3543557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucocutaneous candidiasis and thymoma.
    Stillman MA; Baer RL
    JAMA; 1973 Apr; 224(5):628-9. PubMed ID: 4540647
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological studies in chronic mucocutaneous candidiasis before and after ketoconazole treatment.
    Mobacken H; Lindholm L; Moberg S
    Acta Derm Venereol; 1987; 67(3):257-60. PubMed ID: 2442942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
    Kikuchi T; Uehara S; Ariga H; Tokunaga T; Kariyone A; Tamura T; Takatsu K
    Immunology; 2006 Jan; 117(1):47-58. PubMed ID: 16423040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucocutaneous candidiasis in an immunosuppressed patient].
    Ragni G; Giampaoli T
    Riv Ital Stomatol; 1982; 51(4):369-72. PubMed ID: 6960454
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic mucocutaneous candidiasis associated with malignant thymoma and systemic lupus erythematosus with hypergammaglobulinemia: a case report and literature review.
    San Filippo J
    Cutis; 2006 Jul; 78(1):57-60. PubMed ID: 16903322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid cell vaccination in cancer immunotherapy. Recruitment and activation of T cell help for induction of anti tumour cytotoxic T cells.
    Stuhler G; Trefzer U; Walden P
    Adv Exp Med Biol; 1998; 451():277-82. PubMed ID: 10026885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.